Status:
COMPLETED
ProtocoL for GFR Measurement Using Iohexol (SCOPE-PLUS) - A Substudy of the SCOPE Study
Lead Sponsor:
Istituto Nazionale di Ricovero e Cura per Anziani
Collaborating Sponsors:
Erasmus Medical Center
Institut Catala de Salut
Conditions:
Chronic Kidney Diseases
Eligibility:
All Genders
75+ years
Brief Summary
SCOPE-PLUS is an optional substudy of the observational SCOPE Study (Screening for Chronic Kidney Disease among Older People across Europe, NCT02691546). The objective of the SCOPE-PLUS study is to de...
Detailed Description
SCOPE-PLUS is an optional substudy of the SCOPE cohort study (Screening for Chronic Kidney Disease among Older People across Europe, NCT02691546). SCOPE has retrieved data on a wide panel of biomarker...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- to be eligible for this study, subjects must have been enrolled in the SCOPE study
- Exclusion Criteria for substudy:
- a thyroid-stimulating hormone level less than 0.3 mlU/L
- a known iodine allergy
- oedema
- ascites
- clinically symptomatic heart failure
Exclusion
Key Trial Info
Start Date :
August 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04449172
Start Date
August 8 2019
End Date
August 30 2021
Last Update
March 5 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
MEDIZINISCHE UNIVERSITAT- Internal Medicine/Nephrology/Geriatric Department
Graz, Austria, 8036
2
INRCA Research Hospital
Ancona, Italy, 60131
3
INRCA Research Hospital
Cosenza, Italy
4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM-Department of Internal Medicine
Rotterdam, Netherlands, 3015CE